购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Ephrin Receptor
    (2)
  • Src
    (1)
  • Others
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (3)
  • 6-8周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "eph inhibitor-2"的结果
筛选
搜索结果
TargetMol产品目录中 "

eph inhibitor-2

"的结果
  • 抑制剂&激动剂
    4
    TargetMol | Inhibitors_Agonists
  • Eph inhibitor 2
    Ehp-inhibitor-1
    T5451861249-59-4
    Eph inhibitor 2 是一种 Eph 家族酪氨酸激酶抑制剂。
    • ¥ 595
    In stock
    规格
    数量
  • SI-2 hydrochloride
    EPH 116 hydrochloride
    T129061992052-49-9
    SI-2 hydrochloride (EPH 116 hydrochloride) 是 SRC-3 的抑制剂,诱导乳腺癌细胞死亡的 IC50 值为 3-20 nM。SI-2 hydrochloride 具有良好的药代动力学特征和改善的毒性,以及可接受的口服可用性。
    • ¥ 198
    In stock
    规格
    数量
    TargetMol | Inhibitor Sale
  • Ehp-inhibitor-2
    T5452861249-77-6
    Ehp-inhibitor-2 是一种靶向 Eph 受体的 Eph 家族酪氨酸激酶抑制剂。
    • ¥ 685
    In stock
    规格
    数量
  • LY2457546
    T68389908265-94-1
    LY2457546 is a potent and orally bioavailable inhibitor of multiple receptor tyrosine kinases involved in angiogenic and tumorigenic signalling. LY2457546 demonstrates potent activity against targets that include VEGFR2 (KDR), PDGFRβ, FLT-3, Tie-2 and members of the Eph family of receptors. In vivo, LY2457546 inhibited VEGF-driven autophosphorylation of lung KDR in the mouse and rat in a dose and concentration dependent manner. LY2457546 was well tolerated and exhibited efficacy in a 13762 syngeneic rat mammary tumor models. Additionally, LY2457546 caused complete regression of well-established tumors in an acute myelogenous leukemia (AML) FLT3-ITD mutant xenograft tumor model. The unique spectrum of target activity, potent in vivo anti-tumor efficacy in a variety of rodent and human solid tumor models, exquisite potency against a clinically relevant model of AML, and non-clinical safety profile justify the advancement of LY2457546 into clinical testing. (source: Invest New D......
    • ¥ 11700
    6-8周
    规格
    数量